ArticleACS synthetic biology2025
RNA Polymerase III Promoters Compatible with CRISPR Gene Regulation in
Kendreze L Holland, Ines Blancher, Marisa McKesey, Michael Silas, Siddhant Gandhi, Axum Nickerson, Kennedy Jackson, John Blazeck
Abstract read
In one paragraphArticle in ACS synthetic biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Kendreze L HollandDepartment of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Ines BlancherSchool of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Marisa McKeseySchool of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Michael SilasSchool of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Siddhant GandhiSchool of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Axum NickersonBioengineering Program, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Kennedy JacksonBioengineering Program, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
John BlazeckBioengineering Program, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.ORCID 0000-0002-6110-2938 Funding
Synthetic metabolism to armor and enhance a new class of cell therapiesDP2CA280622 · NCI · GEORGIA INSTITUTE OF TECHNOLOGY · PI BLAZECK, JOHN JAMES · 2022 to 2025
$2.3MNCI NIH HHS DP2 CA280622
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Clustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Cas SystemsPromoter Regions, GeneticRNA Polymerase IIISaccharomyces cerevisiaeGene Expression Regulation, FungalKluyveromycesRNA, Guide, CRISPR-Cas SystemsRNA, Guide, CRISPR-Cas SystemsRNA Polymerase IIICRISPRcross-species functionpol III promotertranscriptional regulationtRNAyeast
Identifiers
PMID40824237
PMCPMC12455662
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390